enVVeno Medical (NVNO) Change in Accured Expenses (2017 - 2026)

enVVeno Medical's Change in Accured Expenses history runs 10 years deep, the most recent figure standing at $15000.0 for Q1 2026.

• In Q1 2026, Change in Accured Expenses rose 103.41% year-over-year to $15000.0; the TTM figure through Mar 2026 stood at $456000.0 (up 208.11% YoY), while the FY2025 annual figure was $1000.0, down 99.86% from the prior year.
• Change in Accured Expenses was $15000.0 for Q1 2026 at enVVeno Medical, up from -$382000.0 in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $1.3 million in Q2 2025 to a low of -$667000.0 in Q4 2023.
• Historically, Change in Accured Expenses has averaged $21764.7 across 5 years, with a median of $15000.0 in 2026.
• Biggest YoY gain for Change in Accured Expenses was 1590.7% in 2023; the steepest drop was 605.3% in 2023.
• A 5-year view of Change in Accured Expenses shows it stood at $132000.0 in 2022, then plunged by 605.3% to -$667000.0 in 2023, then soared by 78.86% to -$141000.0 in 2024, then plunged by 170.92% to -$382000.0 in 2025, then jumped by 103.93% to $15000.0 in 2026.
• The last three Change in Accured Expenses figures came in at $15000.0 (Q1 2026), -$382000.0 (Q4 2025), and -$524000.0 (Q3 2025), per Business Quant data.